{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:37:41Z","timestamp":1791322661747,"version":"4.3.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Matrine, a bioactive isoquinoline alkaloid, exhibits antitumor efficacy by modulating multiple signaling pathways to suppress cancer cell proliferation, migration and invasion. However, its metabolic regulatory mechanisms in prostate cancer intervention require systematic characterization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We implemented matrix-assisted laser desorption\/ionization mass spectrometry imaging (MALDI-MSI) for spatial metabolomic profiling of prostate tissues, integrated with multivariate analytical approaches including principal component analysis, Pearson correlation-based clustering heatmap, partial least squares-discriminant analysis, and hierarchical clustering heatmap analysis. This multimodal strategy enabled comparative evaluation of low-molecular-weight metabolite distributions across normal control, prostate cancer, and matrine-treated prostate cancer cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multi-omics integration identified 19 discriminant metabolites (VIP &amp;gt;1.0) spanning lipid signaling mediators (choline, glycerophosphoglycerol, sphinganine, glycerophosphoinositol, linoleic acid, oleic acid, N,N-Dimethylsphingosine), amino acid network regulators (cysteic acid, 5-Hydroxylysine, glutamine-glutamate axis components), nucleotide biosynthesis (adenine, Ribose 1,5-bisphosphate, uracil, dihydrouracil, deoxyinosine, adenosine), markers of oxidative damage (8-Hydroxyguanine) and cofactor of nitric oxide synthases and aromatic amino acid hydroxylases (tetrahydropteridine). Linoleic acid, oleic acid, and N,N-Dimethylsphingosine exhibited the highest levels in the NC group; these metabolites were significantly downregulated in the PCa group and partially restored in the PCa+MAT group. In addition, the results revealed a progressive depletion of tetrahydropteridine across experimental groups, with the PCa+MAT group exhibiting significantly lower tetrahydropteridine levels compared to both NC and PCa groups (PCa+MAT &amp;lt; NC &amp;lt; PCa). Notably, the expression levels of other compounds were the lowest in the NC group, while they were significantly upregulated in the PCa group and with intermediate levels observed in the PCa+MAT group. Spatial metabolomics delineated dynamic metabolic reprogramming during prostate cancer progression, with matrine treatment demonstrating partial reversal of cancer-associated metabolic shifts, particularly in lipid pathways, underscoring its potential as a modulator of oncogenic metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study establishes MALDI-MSI as a powerful platform for pharmacometabolomic evaluation, while elucidating matrine\u2019s therapeutic potential through coordinated regulation of lipid metabolic remodeling, amino acid\/nucleotide biosynthesis pathways and oxidative stress responses. Our findings provide mechanistic insights into matrine\u2019s anticancer action and validate metabolomic approaches for natural product evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1627864","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:41:36Z","timestamp":1766040096000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Multimode MALDI-MSI deciphers matrine-induced metabolic reprogramming in prostate cancer xenografts: spatial mapping of low-molecular-weight compound alterations"],"prefix":"10.3389","volume":"16","author":[{"given":"Jia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors-a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"101424","DOI":"10.1016\/j.mtbio.2024.101424","article-title":"ECM-mimicking hydrogel models of human adipose tissue identify deregulated lipid metabolism in the prostate cancer-adipocyte crosstalk under antiandrogen therapy","volume":"30","author":"Bessot","year":"2025","journal-title":"Mater. Today Bio"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1039\/d3ob00179b","article-title":"Synthesis and conformational preferences of peptides and proteins with cysteine sulfonic acid","volume":"21","author":"Bhatt","year":"2023","journal-title":"Org. Biomol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.31083\/j.fbe1501002","article-title":"Targeting glutamine metabolism in prostate cancer","volume":"15","author":"Bhowmick","year":"2023","journal-title":"Front. Bioscience (Elite Edition)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.tem.2021.03.003","article-title":"Amino acid depletion therapies: starving cancer cells to death","volume":"32","author":"Butler","year":"2021","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e18761429350210","DOI":"10.2174\/0118761429350210250102131611","article-title":"Chrysin: a potential antiandrogen ligand to mutated androgen receptors in prostate cancer","volume":"17","author":"Carranza-Aranda","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/nprot.2011.388","article-title":"Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry","volume":"6","author":"Casadonte","year":"2011","journal-title":"Nat. Protocols"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1124\/dmd.122.001069","article-title":"Recent advances in mass spectrometry-based spatially resolved molecular imaging of drug disposition and metabolomics","volume":"51","author":"Chen","year":"2023","journal-title":"Drug Metab. Disposition Biol. Fate Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"113404","DOI":"10.1016\/j.intimp.2024.113404","article-title":"N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification","volume":"143","author":"Deng","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/ph17121564","article-title":"Sparstolonin B reduces estrogen-dependent proliferation in cancer cells: possible role of ceramide and PI3K\/AKT\/mTOR inhibition","volume":"17","author":"Dilber","year":"2024","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tcb.2024.04.008","article-title":"Role of lipids in interorganelle communication","volume":"35","author":"Domingues","year":"2025","journal-title":"Trends Cell Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"9546","DOI":"10.3390\/ijms22179546","article-title":"The role of the BH4 cofactor in nitric oxide synthase activity and cancer progression: two sides of the same coin","volume":"22","author":"Gon\u00e7alves","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40364-024-00678-7","article-title":"Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance","volume":"12","author":"Gregg","year":"2024","journal-title":"Biomark. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3892\/ol.2020.12327","article-title":"Effects of matrine in combination with cisplatin on liver cancer","volume":"21","author":"Hu","year":"2021","journal-title":"Oncol. Lett."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1047507","DOI":"10.3389\/fphar.2022.1047507","article-title":"Effects of Sophora flavescens aiton and the absorbed bioactive metabolite matrine individually and in combination with 5-fluorouracil on proliferation and apoptosis of gastric cancer cells in nude mice","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/jcrt.JCRT_862_16","article-title":"Oxidative stress and its role in cancer","volume":"17","author":"Jelic","year":"2021","journal-title":"J. Cancer Res. Therapeutics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1399065","DOI":"10.3389\/fcell.2024.1399065","article-title":"Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways","volume":"12","author":"Khan","year":"2024","journal-title":"Front. Cell Develop. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s11427-016-9050-6","article-title":"Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells","volume":"61","author":"Li","year":"2018","journal-title":"Sci. China Life Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"10125","DOI":"10.2147\/cmar.S213419","article-title":"The effects of matrine in combination with docetaxel on castration-resistant (androgen-independent) prostate cancer","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manage. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"113682","DOI":"10.1016\/j.jep.2020.113682","article-title":"Matrine: a review of its pharmacology, pharmacokinetics, toxicity, clinical application and preparation researches","volume":"269","author":"Li","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/dddt.S349678","article-title":"Matrine exerts pharmacological effects through multiple signaling pathways: a comprehensive review","volume":"16","author":"Lin","year":"2022","journal-title":"Drug Design Develop. Therapy"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20231382","article-title":"Connecting dots between nucleotide biosynthesis and DNA lesion repair\/bypass in cancer","volume":"44","author":"Lin","year":"2024","journal-title":"Biosci. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"114236","DOI":"10.1016\/j.celrep.2024.114236","article-title":"Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response","volume":"43","author":"Lior","year":"2024","journal-title":"Cell Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tcb.2023.09.001","article-title":"The ubiquitous role of ubiquitination in lipid metabolism","volume":"34","author":"Loix","year":"2024","journal-title":"Trends Cell Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41388-021-01667-y","article-title":"Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation","volume":"40","author":"Ma","year":"2021","journal-title":"Oncogene"},{"key":"B27","doi-asserted-by":"publisher","first-page":"17588359241307814","DOI":"10.1177\/17588359241307814","article-title":"Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapy","volume":"16","author":"Mellor","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/pros.24654","article-title":"Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer","volume":"84","author":"Moon","year":"2024","journal-title":"Prostate"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.3390\/cancers15174297","article-title":"Effectiveness of treatments that alter metabolomics in cancer patients-a systematic review","volume":"15","author":"Navarro","year":"2023","journal-title":"Cancers"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1353787","DOI":"10.3389\/fimmu.2024.1353787","article-title":"Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy","volume":"15","author":"Nicolini","year":"2024","journal-title":"Front. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40291-019-00401-5","article-title":"S1PR1 as a novel promising therapeutic target in cancer therapy","volume":"23","author":"Rostami","year":"2019","journal-title":"Mol. Diagnosis Therapy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1126\/science.adh2771","article-title":"Pyrimidines maintain mitochondrial pyruvate oxidation to support de novo lipogenesis","volume":"383","author":"Sahu","year":"2024","journal-title":"Science (New York, NY)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"B34","doi-asserted-by":"publisher","first-page":"977374","DOI":"10.3389\/fnins.2022.977374","article-title":"Research progress on the pharmacological effects of matrine","volume":"16","author":"Sun","year":"2022","journal-title":"Front. Neuroscience"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","article-title":"The pentose phosphate pathway in health and disease","volume":"5","author":"TeSlaa","year":"2023","journal-title":"Nat. Metabolism"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.3390\/cancers14102491","article-title":"Antagonizing glutamine bioavailability promotes radiation sensitivity in prostate cancer","volume":"14","author":"Thiruvalluvan","year":"2022","journal-title":"Cancers"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1016\/j.cell.2024.05.011","article-title":"De novo and salvage purine synthesis pathways across tissues and tumors","volume":"187","author":"Tran","year":"2024","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"107213","DOI":"10.1016\/j.phrs.2024.107213","article-title":"Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: insights from preclinical and clinical studies' outcomes","volume":"204","author":"Ullah","year":"2024","journal-title":"Pharmacol. Research"},{"key":"B39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1515\/hmbci-2023-0012","article-title":"microRNAs, oxidative stress, and genotoxicity as the main inducers in the pathobiology of cancer development","volume":"45","author":"Vahidi","year":"2024","journal-title":"Hormone Mol. Biol. Clin. Investig."},{"key":"B40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13058-025-01991-1","article-title":"Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells","volume":"27","author":"Ward","year":"2025","journal-title":"Breast Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"101925","DOI":"10.1016\/j.tranon.2024.101925","article-title":"Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer","volume":"44","author":"Wei","year":"2024","journal-title":"Transl. Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.32604\/or.2024.048054","article-title":"TMED3 promotes prostate cancer via FOXO1a and FOXO3a phosphorylation","volume":"33","author":"Wei","year":"2025","journal-title":"Oncol. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12944-024-02024-0","article-title":"Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy","volume":"23","author":"Wu","year":"2024","journal-title":"Lipids Health Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e2012748118","DOI":"10.1073\/pnas.2012748118","article-title":"A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer","volume":"118","author":"Xu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B45","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/ijms26020776","article-title":"Cellular signaling of amino acid metabolism in prostate cancer","volume":"26","author":"Yao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.7150\/jca.48906","article-title":"Changes in phospholipid metabolism in exosomes of hormone-sensitive and hormone-resistant prostate cancer cells","volume":"12","author":"Yi","year":"2021","journal-title":"J. Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.32604\/or.2024.048007","article-title":"Caffeic acid hinders the proliferation and migration through inhibition of IL-6 mediated JAK-STAT-3 signaling axis in human prostate cancer","volume":"32","author":"Yin","year":"2024","journal-title":"Oncol. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"01067","DOI":"10.3389\/fphar.2020.01067","article-title":"A systematic review of the pharmacology, toxicology and pharmacokinetics of matrine","volume":"11","author":"You","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3389\/fphar.2020.00588","article-title":"Matrine: a promising natural product with various pharmacological activities","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"107234","DOI":"10.1016\/j.phrs.2024.107234","article-title":"PROTACs targeting androgen receptor signaling: potential therapeutic agents for castration-resistant prostate cancer","volume":"205","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/aja2022105","article-title":"The role of glutamine metabolism in castration-resistant prostate cancer","volume":"25","author":"Zhao","year":"2023","journal-title":"Asian J. Androl."},{"key":"B52","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.18632\/aging.205803","article-title":"Sphingolipids in prostate cancer prognosis: integrating single-cell and bulk sequencing","volume":"16","author":"Zhou","year":"2024","journal-title":"Aging"},{"key":"B53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/ppo.0000000000000740","article-title":"New metabolomic insights into cancer","volume":"30","author":"Zhu","year":"2024","journal-title":"Cancer J. (Sudbury, Mass)"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1627864\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:41:39Z","timestamp":1766040099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1627864\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":53,"alternative-id":["10.3389\/fphar.2025.1627864"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1627864","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"1627864"}}